 | • レポートコード：GIR-105X00865 • 出版社/出版日：GlobalInfoResearch / 2021年5月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、アメーバ症治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。アメーバ症治療薬の種類別市場規模（メトロニダゾール、パロモマイシン、チニダゾール、その他）、用途別市場規模（病院、薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・アメーバ症治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Dr. Reddy’s Laboratories、Mission Pharmacal、Aceto Corporation、Mylan Pharmaceuticals、Impax Laboratories、Pfizer、Sanofi、Lupin Pharmaceuticals、Glenmark Pharmaceuticals、Sun Pharmaceutical、Heritage Pharmaceuticals ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：メトロニダゾール、パロモマイシン、チニダゾール、その他 ・用途別分析2016年-2026年：病院、薬局 ・アメーバ症治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・アメーバ症治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・アメーバ症治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・アメーバ症治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・アメーバ症治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Amebiasis Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Amebiasis Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Amebiasis Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Amebiasis Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Metronidazole
Paromomycin
Tinidazole
Other
Market segment by Application can be divided into
Hospital
Pharmacy
The key market players for global Amebiasis Drugs market are listed below:
Dr. Reddy’s Laboratories
Mission Pharmacal
Aceto Corporation
Mylan Pharmaceuticals
Impax Laboratories
Pfizer
Sanofi
Lupin Pharmaceuticals
Glenmark Pharmaceuticals
Sun Pharmaceutical
Heritage Pharmaceuticals
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Amebiasis Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Amebiasis Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Metronidazole
1.2.3 Paromomycin
1.2.4 Tinidazole
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Amebiasis Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Amebiasis Drugs Market Size & Forecast
1.4.1 Global Amebiasis Drugs Sales in Value (2016-2026))
1.4.2 Global Amebiasis Drugs Sales in Volume (2016-2026)
1.4.3 Global Amebiasis Drugs Price by Type (2016-2026) & (USD/MT)
1.5 Global Amebiasis Drugs Production Capacity Analysis
1.5.1 Global Amebiasis Drugs Total Production Capacity (2016-2026)
1.5.2 Global Amebiasis Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Amebiasis Drugs Market Drivers
1.6.2 Amebiasis Drugs Market Restraints
1.6.3 Amebiasis Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Dr. Reddy’s Laboratories
2.1.1 Dr. Reddy’s Laboratories Details
2.1.2 Dr. Reddy’s Laboratories Major Business
2.1.3 Dr. Reddy’s Laboratories Amebiasis Drugs Product and Services
2.1.4 Dr. Reddy’s Laboratories Amebiasis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Mission Pharmacal
2.2.1 Mission Pharmacal Details
2.2.2 Mission Pharmacal Major Business
2.2.3 Mission Pharmacal Amebiasis Drugs Product and Services
2.2.4 Mission Pharmacal Amebiasis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Aceto Corporation
2.3.1 Aceto Corporation Details
2.3.2 Aceto Corporation Major Business
2.3.3 Aceto Corporation Amebiasis Drugs Product and Services
2.3.4 Aceto Corporation Amebiasis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Mylan Pharmaceuticals
2.4.1 Mylan Pharmaceuticals Details
2.4.2 Mylan Pharmaceuticals Major Business
2.4.3 Mylan Pharmaceuticals Amebiasis Drugs Product and Services
2.4.4 Mylan Pharmaceuticals Amebiasis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Impax Laboratories
2.5.1 Impax Laboratories Details
2.5.2 Impax Laboratories Major Business
2.5.3 Impax Laboratories Amebiasis Drugs Product and Services
2.5.4 Impax Laboratories Amebiasis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Amebiasis Drugs Product and Services
2.6.4 Pfizer Amebiasis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Amebiasis Drugs Product and Services
2.7.4 Sanofi Amebiasis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Lupin Pharmaceuticals
2.8.1 Lupin Pharmaceuticals Details
2.8.2 Lupin Pharmaceuticals Major Business
2.8.3 Lupin Pharmaceuticals Amebiasis Drugs Product and Services
2.8.4 Lupin Pharmaceuticals Amebiasis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Glenmark Pharmaceuticals
2.9.1 Glenmark Pharmaceuticals Details
2.9.2 Glenmark Pharmaceuticals Major Business
2.9.3 Glenmark Pharmaceuticals Amebiasis Drugs Product and Services
2.9.4 Glenmark Pharmaceuticals Amebiasis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Sun Pharmaceutical
2.10.1 Sun Pharmaceutical Details
2.10.2 Sun Pharmaceutical Major Business
2.10.3 Sun Pharmaceutical Amebiasis Drugs Product and Services
2.10.4 Sun Pharmaceutical Amebiasis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Heritage Pharmaceuticals
2.11.1 Heritage Pharmaceuticals Details
2.11.2 Heritage Pharmaceuticals Major Business
2.11.3 Heritage Pharmaceuticals Amebiasis Drugs Product and Services
2.11.4 Heritage Pharmaceuticals Amebiasis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Amebiasis Drugs Sales by Manufacturer
3.1 Global Amebiasis Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Amebiasis Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Amebiasis Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Amebiasis Drugs Manufacturer Market Share
3.4.2 Top 6 Amebiasis Drugs Manufacturer Market Share
3.5 Global Amebiasis Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Amebiasis Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Amebiasis Drugs Market Size by Region
4.1.1 Global Amebiasis Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Amebiasis Drugs Revenue by Region (2016-2026)
4.2 North America Amebiasis Drugs Revenue (2016-2026)
4.3 Europe Amebiasis Drugs Revenue (2016-2026)
4.4 Asia-Pacific Amebiasis Drugs Revenue (2016-2026)
4.5 South America Amebiasis Drugs Revenue (2016-2026)
4.6 Middle East and Africa Amebiasis Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Amebiasis Drugs Sales in Volume by Type (2016-2026)
5.2 Global Amebiasis Drugs Revenue by Type (2016-2026)
5.3 Global Amebiasis Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Amebiasis Drugs Sales in Volume by Application (2016-2026)
6.2 Global Amebiasis Drugs Revenue by Application (2016-2026)
6.3 Global Amebiasis Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Amebiasis Drugs Sales by Type (2016-2026)
7.2 North America Amebiasis Drugs Sales by Application (2016-2026)
7.3 North America Amebiasis Drugs Market Size by Country
7.3.1 North America Amebiasis Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Amebiasis Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Amebiasis Drugs Sales by Type (2016-2026)
8.2 Europe Amebiasis Drugs Sales by Application (2016-2026)
8.3 Europe Amebiasis Drugs Market Size by Country
8.3.1 Europe Amebiasis Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Amebiasis Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Amebiasis Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Amebiasis Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Amebiasis Drugs Market Size by Region
9.3.1 Asia-Pacific Amebiasis Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Amebiasis Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Amebiasis Drugs Sales by Type (2016-2026)
10.2 South America Amebiasis Drugs Sales by Application (2016-2026)
10.3 South America Amebiasis Drugs Market Size by Country
10.3.1 South America Amebiasis Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Amebiasis Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Amebiasis Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Amebiasis Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Amebiasis Drugs Market Size by Country
11.3.1 Middle East & Africa Amebiasis Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Amebiasis Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Amebiasis Drugs Typical Distributors
12.3 Amebiasis Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Amebiasis Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Amebiasis Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Dr. Reddy’s Laboratories Basic Information, Manufacturing Base and Competitors
Table 4. Dr. Reddy’s Laboratories Major Business
Table 5. Dr. Reddy’s Laboratories Amebiasis Drugs Product and Services
Table 6. Dr. Reddy’s Laboratories Amebiasis Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Mission Pharmacal Basic Information, Manufacturing Base and Competitors
Table 8. Mission Pharmacal Major Business
Table 9. Mission Pharmacal Amebiasis Drugs Product and Services
Table 10. Mission Pharmacal Amebiasis Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Aceto Corporation Basic Information, Manufacturing Base and Competitors
Table 12. Aceto Corporation Major Business
Table 13. Aceto Corporation Amebiasis Drugs Product and Services
Table 14. Aceto Corporation Amebiasis Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Mylan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Mylan Pharmaceuticals Major Business
Table 17. Mylan Pharmaceuticals Amebiasis Drugs Product and Services
Table 18. Mylan Pharmaceuticals Amebiasis Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Impax Laboratories Basic Information, Manufacturing Base and Competitors
Table 20. Impax Laboratories Major Business
Table 21. Impax Laboratories Amebiasis Drugs Product and Services
Table 22. Impax Laboratories Amebiasis Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Pfizer Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer Major Business
Table 25. Pfizer Amebiasis Drugs Product and Services
Table 26. Pfizer Amebiasis Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Sanofi Basic Information, Manufacturing Base and Competitors
Table 28. Sanofi Major Business
Table 29. Sanofi Amebiasis Drugs Product and Services
Table 30. Sanofi Amebiasis Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Lupin Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Lupin Pharmaceuticals Major Business
Table 33. Lupin Pharmaceuticals Amebiasis Drugs Product and Services
Table 34. Lupin Pharmaceuticals Amebiasis Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 36. Glenmark Pharmaceuticals Major Business
Table 37. Glenmark Pharmaceuticals Amebiasis Drugs Product and Services
Table 38. Glenmark Pharmaceuticals Amebiasis Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 40. Sun Pharmaceutical Major Business
Table 41. Sun Pharmaceutical Amebiasis Drugs Product and Services
Table 42. Sun Pharmaceutical Amebiasis Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Heritage Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. Heritage Pharmaceuticals Major Business
Table 45. Heritage Pharmaceuticals Amebiasis Drugs Product and Services
Table 46. Heritage Pharmaceuticals Amebiasis Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global Amebiasis Drugs Sales by Manufacturer (2019-2021e) & (K MT)
Table 48. Global Amebiasis Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in Amebiasis Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global Amebiasis Drugs Production Capacity by Company, (K MT): 2020 VS 2021
Table 51. Head Office and Amebiasis Drugs Production Site of Key Manufacturer
Table 52. Global Amebiasis Drugs Sales by Region (2016-2021e) & (K MT)
Table 53. Global Amebiasis Drugs Sales by Region (2021-2026) & (K MT)
Table 54. Global Amebiasis Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 55. Global Amebiasis Drugs Revenue by Region (2021-2026) & (USD Million)
Table 56. Global Amebiasis Drugs Sales by Type (2016-2021e) & (K MT)
Table 57. Global Amebiasis Drugs Sales by Type (2021-2026) & (K MT)
Table 58. Global Amebiasis Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 59. Global Amebiasis Drugs Revenue by Type (2021-2026) & (USD Million)
Table 60. Global Amebiasis Drugs Price by Type (2016-2021e) & (USD/MT)
Table 61. Global Amebiasis Drugs Price by Type (2021-2026) & (USD/MT)
Table 62. Global Amebiasis Drugs Sales by Application (2016-2021e) & (K MT)
Table 63. Global Amebiasis Drugs Sales by Application (2021-2026) & (K MT)
Table 64. Global Amebiasis Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 65. Global Amebiasis Drugs Revenue by Application (2021-2026) & (USD Million)
Table 66. Global Amebiasis Drugs Price by Application (2016-2021e) & (USD/MT)
Table 67. Global Amebiasis Drugs Price by Application (2021-2026) & (USD/MT)
Table 68. North America Amebiasis Drugs Sales by Country (2016-2021e) & (K MT)
Table 69. North America Amebiasis Drugs Sales by Country (2021-2026) & (K MT)
Table 70. North America Amebiasis Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 71. North America Amebiasis Drugs Revenue by Country (2021-2026) & (USD Million)
Table 72. North America Amebiasis Drugs Sales by Type (2016-2021e) & (K MT)
Table 73. North America Amebiasis Drugs Sales by Type (2021-2026) & (K MT)
Table 74. North America Amebiasis Drugs Sales by Application (2016-2021e) & (K MT)
Table 75. North America Amebiasis Drugs Sales by Application (2021-2026) & (K MT)
Table 76. Europe Amebiasis Drugs Sales by Country (2016-2021e) & (K MT)
Table 77. Europe Amebiasis Drugs Sales by Country (2021-2026) & (K MT)
Table 78. Europe Amebiasis Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 79. Europe Amebiasis Drugs Revenue by Country (2021-2026) & (USD Million)
Table 80. Europe Amebiasis Drugs Sales by Type (2016-2021e) & (K MT)
Table 81. Europe Amebiasis Drugs Sales by Type (2021-2026) & (K MT)
Table 82. Europe Amebiasis Drugs Sales by Application (2016-2021e) & (K MT)
Table 83. Europe Amebiasis Drugs Sales by Application (2021-2026) & (K MT)
Table 84. Asia-Pacific Amebiasis Drugs Sales by Region (2016-2021e) & (K MT)
Table 85. Asia-Pacific Amebiasis Drugs Sales by Region (2021-2026) & (K MT)
Table 86. Asia-Pacific Amebiasis Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 87. Asia-Pacific Amebiasis Drugs Revenue by Region (2021-2026) & (USD Million)
Table 88. Asia-Pacific Amebiasis Drugs Sales by Type (2016-2021e) & (K MT)
Table 89. Asia-Pacific Amebiasis Drugs Sales by Type (2021-2026) & (K MT)
Table 90. Asia-Pacific Amebiasis Drugs Sales by Application (2016-2021e) & (K MT)
Table 91. Asia-Pacific Amebiasis Drugs Sales by Application (2021-2026) & (K MT)
Table 92. South America Amebiasis Drugs Sales by Country (2016-2021e) & (K MT)
Table 93. South America Amebiasis Drugs Sales by Country (2021-2026) & (K MT)
Table 94. South America Amebiasis Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 95. South America Amebiasis Drugs Revenue by Country (2021-2026) & (USD Million)
Table 96. South America Amebiasis Drugs Sales by Type (2016-2021e) & (K MT)
Table 97. South America Amebiasis Drugs Sales by Type (2021-2026) & (K MT)
Table 98. South America Amebiasis Drugs Sales by Application (2016-2021e) & (K MT)
Table 99. South America Amebiasis Drugs Sales by Application (2021-2026) & (K MT)
Table 100. Middle East & Africa Amebiasis Drugs Sales by Country (2016-2021e) & (K MT)
Table 101. Middle East & Africa Amebiasis Drugs Sales by Country (2021-2026) & (K MT)
Table 102. Middle East & Africa Amebiasis Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 103. Middle East & Africa Amebiasis Drugs Revenue by Country (2021-2026) & (USD Million)
Table 104. Middle East & Africa Amebiasis Drugs Sales by Type (2016-2021e) & (K MT)
Table 105. Middle East & Africa Amebiasis Drugs Sales by Type (2021-2026) & (K MT)
Table 106. Middle East & Africa Amebiasis Drugs Sales by Application (2016-2021e) & (K MT)
Table 107. Middle East & Africa Amebiasis Drugs Sales by Application (2021-2026) & (K MT)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Amebiasis Drugs Typical Distributors
Table 111. Amebiasis Drugs Typical Customers
List of Figures
Figure 1. Amebiasis Drugs Picture
Figure 2. Global Amebiasis Drugs Sales Market Share by Type in 2020
Figure 3. Metronidazole
Figure 4. Paromomycin
Figure 5. Tinidazole
Figure 6. Other
Figure 7. Global Amebiasis Drugs Sales Market Share by Application in 2020
Figure 8. Hospital
Figure 9. Pharmacy
Figure 10. Global Amebiasis Drugs Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 11. Global Amebiasis Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Amebiasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Amebiasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Amebiasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Amebiasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Amebiasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Amebiasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Amebiasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Amebiasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Amebiasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Amebiasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Amebiasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Amebiasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Amebiasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Amebiasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Amebiasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Amebiasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Amebiasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Amebiasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Amebiasis Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Amebiasis Drugs Sales (2016-2026) & (K MT)
Figure 32. Global Amebiasis Drugs Production Capacity (2016-2026) & (K MT)
Figure 33. Global Amebiasis Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Amebiasis Drugs Market Drivers
Figure 35. Amebiasis Drugs Market Restraints
Figure 36. Amebiasis Drugs Market Trends
Figure 37. Global Amebiasis Drugs Sales Market Share by Manufacturer in 2020
Figure 38. Global Amebiasis Drugs Revenue Market Share by Manufacturer in 2020
Figure 39. Amebiasis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Amebiasis Drugs Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Amebiasis Drugs Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Amebiasis Drugs Sales Market Share by Region (2016-2026)
Figure 43. Global Amebiasis Drugs Revenue Market Share by Region (2016-2026)
Figure 44. North America Amebiasis Drugs Revenue (2016-2026) & (USD Million)
Figure 45. Europe Amebiasis Drugs Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Amebiasis Drugs Revenue (2016-2026) & (USD Million)
Figure 47. South America Amebiasis Drugs Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Amebiasis Drugs Revenue (2016-2026) & (USD Million)
Figure 49. Global Amebiasis Drugs Sales Market Share by Type (2016-2026)
Figure 50. Global Amebiasis Drugs Revenue Market Share by Type (2016-2026)
Figure 51. Global Amebiasis Drugs Price by Type (2016-2026) & (USD/MT)
Figure 52. Global Amebiasis Drugs Sales Market Share by Application (2016-2026)
Figure 53. Global Amebiasis Drugs Revenue Market Share by Application (2016-2026)
Figure 54. Global Amebiasis Drugs Price by Application (2016-2026) & (USD/MT)
Figure 55. North America Amebiasis Drugs Sales Market Share by Country (2016-2026)
Figure 56. North America Amebiasis Drugs Revenue Market Share by Country (2016-2026)
Figure 57. North America Amebiasis Drugs Sales Market Share by Type (2016-2026)
Figure 58. North America Amebiasis Drugs Sales Market Share by Application (2016-2026)
Figure 59. Europe Amebiasis Drugs Sales Market Share by Country (2016-2026)
Figure 60. Europe Amebiasis Drugs Revenue Market Share by Country (2016-2026)
Figure 61. Europe Amebiasis Drugs Sales Market Share by Type (2016-2026)
Figure 62. Europe Amebiasis Drugs Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Amebiasis Drugs Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Amebiasis Drugs Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Amebiasis Drugs Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Amebiasis Drugs Sales Market Share by Application (2016-2026)
Figure 67. South America Amebiasis Drugs Sales Market Share by Country (2016-2026)
Figure 68. South America Amebiasis Drugs Revenue Market Share by Country (2016-2026)
Figure 69. South America Amebiasis Drugs Sales Market Share by Type (2016-2026)
Figure 70. South America Amebiasis Drugs Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Amebiasis Drugs Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Amebiasis Drugs Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Amebiasis Drugs Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Amebiasis Drugs Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界のエポプロステノールナトリウム薬品市場 2021：企業別、地域別、種類・用途別 The Epoprostenol Sodium Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…- 世界のブドウ球菌感染症治療薬市場 2021：企業別、地域別、種類・用途別 The Staphylococcal Infection Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 世界のアルギニン血症治療薬市場 2021：企業別、地域別、種類・用途別 The Argininemia Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, …
- 世界の抗コリン作用乗物酔い止め薬市場 2021：企業別、地域別、種類・用途別 The Anticholinergic Travel Sickness Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- 世界の出血性脳卒中治療薬市場 2021：企業別、地域別、種類・用途別 The Haemorrhagic Stroke Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…